Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
posted on
Jan 08, 2018 05:02PM
The NR states:
"Medison will be responsible for all regulatory, sales and marketing costs for apabetalone in the Israel region."
Not sure how many patients were tested in Betonmace in israel. Clinicaltrials.gov lists the following as the main contact in the Betonmace trial.
Lady Davis Carmel Medical Center | |
Haifa, Israel, 34362 |
Reading between the lines - presumably all costs of the Betonmace trial in Israel will be paid by Medison. Not sure what the current tab is. An Israeli partnership is huge - RVX-208 may be marketed in Israel before the US. A safe, effective pill treatment with a successful roll-out in Israel - what better way to get the word out at the grass roots level- knowledge would quickly spread to US physicians - a brilliant marketing plan.
Chicagoest